Mölnlycke's new China-based location is expected to initiate wound care product production at the end of 2026 or early 2027
CHANGSHU, China, and GOTHENBURG, Sweden—Mölnlycke Health Care, a global provider in medical technology, headquartered in Gothenburg, Sweden, announced the commencement of its new wound care manufacturing site in Changshu, China. The company said this investment marks a milestone in Mölnlycke’s growth and the beginning of localized manufacturing in one of the world’s "fastest-growing MedTech markets."
